Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Structural Heart Imaging Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use, Modality, Procedure), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11336| Published Date: Sep-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Structural Heart Imaging Market size was over USD 10.4 billion in 2026 and is likely to grow at a 5.61% CAGR between 2027 and 2036, exceeding USD 17.95 billion by 2036. The industry revenue for 2027 is calculated at USD 10.89 billion.

Base Year Value (2026)
USD 10.4 billion
CAGR (2027-2036)
5.61%
Forecast Year Value (2036)
USD 17.95 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Structural Heart Imaging Market Intelligence Snapshot

Regional Market Dynamics

  • North America held 37.84% share in 2026, driven by advanced cardiac imaging adoption across tertiary hospitals and integration into structural heart intervention planning and procedural workflows.
  • Asia Pacific is growing at 6.78% CAGR due to expanding cardiovascular care access, rising adoption of advanced imaging, and increasing procedural capabilities in developing healthcare systems.

Segment Momentum

  • Interventional cardiology leads due to heavy reliance on real-time imaging for device positioning, procedural guidance, and decision-making in structural heart interventions and catheter-based treatments.
  • Ambulatory surgical centers are expanding rapidly as healthcare shifts toward efficient, outpatient cardiovascular procedures with lower facility burden and streamlined procedural workflows compared to hospitals.

Market Expansion Drivers

  • Rising cardiovascular disease burden increasing demand for advanced diagnostic and interventional imaging systems.
  • Advancements in 3D/4D imaging and AI integration improving precision in cardiac structural assessments.
  • Expanding adoption of minimally invasive cardiac procedures driving need for real-time imaging guidance tools.

Leading Market Participants

  • Key companies in the structural heart imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Abbott Laboratories (United States), United Imaging Healthcare Co., Ltd. (China).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 10.4 billion
  • 2027 Estimated Market Size: USD 10.89 billion.
  • Projected Market Size: USD 17.95 billion by 2036
  • Growth Forecast: 5.61% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Interventional Cardiology (Application) | Hospitals & Clinics (End Use) | Angiogram (Modality) | Transcatheter Aortic Valve Replacement (TAVR) (Procedure)
  • Emerging Opportunity Segment: Interventional Cardiology (Application) | Ambulatory Surgical Centers (End Use) | CT (Modality) | Transcatheter Mitral Valve Repair (TMVR) (Procedure)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising cardiovascular disease burden increasing demand for advanced diagnostic and interventional imaging systems

The growing prevalence of cardiovascular disorders is increasing the need for accurate diagnosis and treatment planning, which will drive the structural heart imaging market growth by expanding demand for sophisticated imaging modalities used to evaluate cardiac anatomy and function. A rising burden of conditions affecting heart valves and other structural components requires detailed visualization to support disease detection, severity assessment, and procedural planning. Advanced echocardiography and other cardiac imaging technologies enable clinicians to obtain clearer anatomical information and assess complex structural abnormalities before selecting appropriate interventions. Increasing awareness of cardiovascular health, broader access to specialized cardiac care, and the need for earlier diagnosis are also encouraging healthcare providers to incorporate advanced imaging systems into diagnostic pathways, particularly for patients requiring detailed structural assessment.

Advancements in 3D/4D imaging and AI integration improving precision in cardiac structural assessments

Technological progress in cardiac visualization is strengthening the capabilities of modern imaging platforms, and 3D and 4D imaging combined with artificial intelligence will propel the structural heart imaging market by enabling more detailed and efficient assessment of complex cardiac structures. Three-dimensional visualization can provide clinicians with a more comprehensive understanding of valve morphology, chamber anatomy, and spatial relationships than conventional two-dimensional imaging alone, while real-time 4D capabilities can support dynamic evaluation of cardiac motion. AI-based image processing can further assist with image interpretation, anatomical segmentation, measurement, and workflow automation, helping clinicians handle complex datasets more efficiently. These capabilities are particularly valuable when precise anatomical information is required for treatment planning and monitoring of structural heart conditions.

Expanding adoption of minimally invasive cardiac procedures driving need for real-time imaging guidance tools

The increasing preference for catheter-based and other minimally invasive approaches to structural heart treatment is creating greater reliance on imaging systems that can provide continuous anatomical guidance during procedures. This trend will boost the structural heart imaging market demand as physicians require high-quality, real-time visualization to navigate instruments, position devices, evaluate treatment results, and identify potential complications during interventions. Imaging guidance can reduce uncertainty in procedures involving delicate cardiac structures by providing immediate feedback on device placement and anatomical changes. Growing clinical interest in less invasive treatment options is also encouraging healthcare facilities to invest in imaging technologies capable of supporting complex interventional workflows, including advanced echocardiographic systems and integrated imaging solutions.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising cardiovascular disease burden increasing demand for advanced diagnostic and interventional imaging systems 2.00% High North America, Europe High Near Term
Advancements in 3D/4D imaging and AI integration improving precision in cardiac structural assessments 1.90% High North America, Asia Pacific High Mid Term
Expanding adoption of minimally invasive cardiac procedures driving need for real-time imaging guidance tools 1.70% Moderate Europe, Asia Pacific High Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Structural Heart Imaging Market
Largest Region
North America
37.84% Market Share in 2026

North America (Largest Region)

North America held the largest share of the structural heart imaging market at 37.84% in 2026, supported by advanced cardiovascular care infrastructure, widespread access to sophisticated diagnostic technologies, and strong clinical adoption of imaging techniques for evaluating structural heart conditions. The region benefits from established specialist care networks and increasing emphasis on accurate pre-procedural assessment and treatment planning, which strengthens demand for advanced imaging capabilities.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region, driven by improving healthcare infrastructure, expanding access to specialized cardiac services, and rising awareness of cardiovascular disease diagnosis and management. Greater healthcare investment and the gradual adoption of advanced imaging technologies are supporting broader diagnostic capabilities across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants/Startups i Scale Low Medium High
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Procedure Planning Excellence

Germany emphasizes structural heart imaging that supports accurate evaluation of complex cardiovascular conditions and interventional procedures. German cardiac centers continue integrating high-resolution imaging systems to improve procedural confidence and multidisciplinary treatment planning.

France 🇫🇷

Interventional Imaging Support

France continues advancing structural heart imaging through close integration of diagnostic imaging with structural cardiac interventions. French healthcare providers are enhancing imaging capabilities that facilitate precise valve assessment, procedural guidance, and comprehensive patient evaluation.

Italy 🇮🇹

Cardiac Care Modernization

Italy supports the structural heart imaging market by expanding access to advanced imaging technologies across specialized cardiovascular centers. Italian clinicians continue adopting sophisticated imaging techniques that strengthen procedural planning and improve management of structural heart conditions.

Japan 🇯🇵

Precision Cardiac Assessment

Japan focuses on structural heart imaging solutions that deliver detailed anatomical visualization for minimally invasive cardiac procedures. Japanese healthcare institutions continue strengthening imaging capabilities to support accurate diagnosis and optimized patient management throughout treatment pathways.

South Korea 🇰🇷

Integrated Imaging Adoption

South Korea is expanding structural heart imaging through investments in advanced cardiovascular imaging technologies and specialized cardiac care programs. Hospitals across South Korea continue integrating multimodal imaging into structural heart procedures to improve clinical workflow and treatment precision.

United States 🇺🇸

Advanced Cardiac Visualization

The U.S. structural heart imaging market is expanding through greater use of multimodality imaging for diagnosis, procedural planning, and post-treatment assessment. Healthcare providers in the U.S. continue adopting advanced imaging technologies that improve precision during complex structural heart interventions.

Segment Analysis

Segment Leadership and Growth Trends

Structural Heart Imaging Market Share (%), by Application, 2026

Interventional Cardiology
Diagnostic Imaging

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Application Segment Analysis: Interventional Cardiology (Largest & Fastest-Growing Segment)

Interventional cardiology accounted for the largest share of the structural heart imaging market in 2026 and is also expected to be the fastest-growing application segment. Structural heart procedures increasingly depend on detailed imaging to assess anatomy, guide minimally invasive interventions, and evaluate procedural outcomes, making advanced imaging an integral part of clinical decision-making. The growing preference for less invasive treatment approaches and the increasing complexity of structural heart procedures are further strengthening demand for precise real-time visualization.

End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals & clinics dominated the structural heart imaging market with a 55.87% share in 2026, reflecting their central role in diagnosing and treating patients with structural cardiac conditions. These facilities typically provide comprehensive cardiovascular services and have access to specialized imaging infrastructure and multidisciplinary clinical teams, supporting sustained utilization of imaging technologies across diagnostic assessment, procedural planning, and follow-up care.

Ambulatory surgical centers are projected to expand at the fastest pace as selected cardiovascular interventions increasingly shift toward outpatient and minimally invasive care settings. Growing emphasis on shorter hospital stays, streamlined procedures, and more efficient healthcare delivery is encouraging the adoption of advanced imaging capabilities in ambulatory environments, particularly where imaging can support accurate intervention planning and procedural guidance.

Segment Sub-Segment Largest Segment Fastest Growing
Application Diagnostic Imaging, Interventional Cardiology Interventional Cardiology Interventional Cardiology
End Use Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Others Hospitals & Clinics Ambulatory Surgical Centers
Modality Echocardiogram, Angiogram, CT, MRI, Nuclear Imaging, Others Angiogram CT
Procedure Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Tricuspid Valve Replacement and Repair, Paravalvular Leak Detection and Repair, Annuloplasty, Valvuloplasty, Others Transcatheter Aortic Valve Replacement (TAVR) Transcatheter Mitral Valve Repair (TMVR)
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the structural heart imaging market:

1. GE HealthCare Technologies Inc. (United States)

2. Siemens Healthineers AG (Germany)

3. Koninklijke Philips N.V. (Netherlands)

4. Canon Medical Systems Corporation (Japan)

5. Fujifilm Holdings Corporation (Japan)

6. Abbott Laboratories (United States)

7. United Imaging Healthcare Co. Ltd. (China)

The structural heart imaging market is evolving through the incorporation of artificial intelligence-assisted diagnostics and advanced imaging visualization technologies. Research activities are focused on improving procedural accuracy, imaging speed, and minimally invasive treatment planning capabilities. Growing adoption of precision cardiology solutions is fostering continuous innovation and competitive advancement within the market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
GE HealthCare Technologies Inc. (United States)
Siemens Healthineers AG (Germany)
Koninklijke Philips N.V. (Netherlands)
Canon Medical Systems Corporation (Japan)
Fujifilm Holdings Corporation (Japan)
Abbott Laboratories (United States)
United Imaging Healthcare Co. Ltd. (China).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Medtronic & Philips Feb-25 Medtronic and Philips signed a Memorandum of Understanding in India to upskill over 300 clinicians in advanced structural heart imaging. The program focuses on multi-modality techniques, including echocardiography and MRI, specifically to improve diagnostic precision and procedural outcomes for complex patient populations, such as those with end-stage renal disease (ESRD), by minimizing the reliance on nephrotoxic contrast agents.
Shanghai United Imaging Healthcare Oct-24 United Imaging Healthcare entered a strategic partnership with medical imaging software provider INVIA to enhance its nuclear cardiology solutions. The collaboration integrates INVIA’s Corridor4DM software into United Imaging’s uOmnispace AI-powered visualization workspace. This integration improves the diagnostic assessment of cardiac function and myocardial perfusion, supporting clinicians in making more informed decisions for structural heart and vascular care.
GE HealthCare Sep-24 GE HealthCare launched the Venue Sprint, a tablet-based point-of-care ultrasound system designed for emergency and critical care environments. The system incorporates AI-enabled diagnostic tools, such as caption guidance for cardiac imaging, to ensure consistency in ultrasound image acquisition. By providing wireless probe connectivity and automated workflow features, the system facilitates rapid, high-quality bedside structural heart assessment and monitoring.
Siemens Healthineers Aug-24 Siemens Healthineers received FDA clearance for the ACUSON Origin, an AI-powered cardiovascular ultrasound system. The platform integrates advanced AI tools for view recognition and automated measurements to streamline structural heart procedures and electrophysiology exams. The clearance also included the AcuNav Lumos 4D ICE catheter, which provides real-time 4D color Doppler imaging to enhance guidance during complex minimally invasive cardiac interventions.
Atrium Health Jun-24 Atrium Health Sanger Heart & Vascular Institute utilized high-resolution structural heart imaging, including cardiac CT and advanced echocardiography, to guide a landmark transcatheter tricuspid clip procedure. This milestone highlights the critical role of specialized imaging expertise in enabling minimally invasive interventions for complex valvular heart disease, reinforcing the institute’s capability in managing "forgotten valve" conditions through precision-guided, catheter-based edge-to-edge repair.
Siemens Healthineers May-24 Siemens Healthineers and University Hospitals (UH) established a 10-year strategic alliance, building upon a 40-year collaboration. The partnership focuses on advancing cardiovascular, neurovascular, and oncology care through the deployment of next-generation imaging technology, including photon-counting CT and advanced angiography systems. This initiative aims to accelerate clinical research and improve patient access to high-precision diagnostic and interventional services across the UH network in Ohio.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Structural Heart Imaging Market — Custom Segments

Segment Sub-Segment
Imaging Guidance Stage Pre-Procedural Imaging, Intra-Procedural Imaging, Post-Procedural Imaging
Reimbursement Model Publicly Reimbursed, Privately Reimbursed, Self-Pay
Imaging Workflow Standalone Imaging, Multimodality Imaging, Integrated Procedural Imaging

Structural Heart Imaging Market — Custom TOC

Custom Chapter Custom Details
Structural Heart Program Expansion Strategy
  • Structural Heart Service-Line Development Priorities
  • Institutional Readiness and Program Capability Requirements
  • Imaging Infrastructure and Multidisciplinary Workflow Needs
  • Expansion Models Across Emerging Procedure Programs
Imaging Technology Adoption Roadmap
  • Technology Adoption Priorities Across Structural Heart Workflows
  • Advanced Imaging Capabilities and Clinical Use-Case Evolution
  • Integration Requirements Across Imaging Modalities and Care Pathways
  • Technology Deployment Sequencing and Investment Priorities
  • Future-State Imaging Architecture
Clinical Workflow Integration Assessment
  • Imaging Workflow Integration Across Structural Heart Procedures
  • Pre-Procedural Planning and Intra-Procedural Imaging Requirements
  • Multidisciplinary Coordination and Workflow Bottlenecks
  • Digital Integration and Operational Efficiency Opportunities

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How big is the structural heart imaging market?

The market valuation of the structural heart imaging is USD 10.89 billion in 2027.

What is the expected industry size of structural heart imaging by 2036?

Structural Heart Imaging Market size was over USD 10.4 billion in 2026 and is likely to grow at a 5.61% CAGR between 2027 and 2036, exceeding USD 17.95 billion by 2036.

How is the rising cardiovascular disease burden influencing investment in structural heart imaging technologies?

Increasing prevalence of structural and valvular heart conditions is driving demand for advanced imaging systems that support accurate diagnosis, procedural planning, and treatment evaluation, leading hospitals to adopt higher-resolution modalities for complex cardiac decision-making.

How is the growth of minimally invasive cardiac procedures affecting imaging requirements in the structural heart imaging market?

The shift toward catheter-based interventions is increasing reliance on real-time imaging tools that guide device placement and assess outcomes during procedures, driving adoption of transesophageal, intracardiac, and fusion imaging systems in clinical workflows.

Why does interventional cardiology dominate structural heart imaging demand?

Interventional cardiology leads due to heavy reliance on real-time imaging for device positioning, procedural guidance, and decision-making in structural heart interventions and catheter-based treatments.

What is driving ambulatory surgical centers’ growth in structural heart imaging?

Ambulatory surgical centers are expanding rapidly as healthcare shifts toward efficient, outpatient cardiovascular procedures with lower facility burden and streamlined procedural workflows compared to hospitals.

Why does North America dominate the structural heart imaging market?

North America held 37.84% share in 2026, driven by advanced cardiac imaging adoption across tertiary hospitals and integration into structural heart intervention planning and procedural workflows.

What is driving Asia Pacific growth in structural heart imaging market?

Asia Pacific is growing at 6.78% CAGR due to expanding cardiovascular care access, rising adoption of advanced imaging, and increasing procedural capabilities in developing healthcare systems.

Who are the major participants shaping the structural heart imaging landscape?

Key companies in the structural heart imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), Abbott Laboratories (United States), United Imaging Healthcare Co., Ltd. (China).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →